Biovail to Participate at Upcoming Conferences

TORONTO--(BUSINESS WIRE)--Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the Company will participate at the Credit Suisse 18^th Annual Global Healthcare Conference at the Arizona Biltmore Resort in Phoenix, Arizona and at the Lazard Capital Markets 6^th Annual Healthcare Conference at the St. Regis Hotel in New York City.

Biovail’s Credit Suisse presentation is scheduled for Thursday, November 12, 2009 at 5:00pm MST (7:00pm EST). The Lazard Capital Markets presentation is scheduled for November 18, 2009 at 2:45 pm EST. A live and archived Webcast will be available on the Investor Relations page of Biovail’s Web site at www.biovail.com.

About Biovail Corporation

Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets. For more information about Biovail, visit the Company’s Web site at www.biovail.com.

For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to [e-mail].